21 cfr part 50 - Study guides, Class notes & Summaries

CCRP SoCRA Exam Cert Exam Questions with Verified Answers 2024 21 CFR Part 11 - CORRECT ANSWER-Electronic Records; Electronic Signatures 21 CFR Part 11 Subpart B - CORRECT ANSWER-Electronic Records 21 CFR Part 11 Subpart C - CORRECT ANSWER-Electronic Signatures 21 CFR Part 50 - CORRECT ANSWER-Protection of Human Subjects 21 CFR Part 50 Subpart B - CORRECT ANSWER-Informed Consent of Human Subjects 21 CFR Part 50 Subpart D - CORRECT ANSWER-Additional Safeguards for Children in Clinical ...

SoCRA Certification Exam 2023 with complete answers Biometrics A method of verifying an individual's identity based on measurement of the individual's physical features or repeatable actions where those features and or actions are both unique to that individual and measurable. (21 CFR, Sec. 11.3) Closed System An environment in which system access is controlled by persons who are responsible for the content of electronic records that are on the system. (21 CFR, Sec. 11.3) Digi...

Quality - ANSWER -ICH Q Efficacy - ANSWER -ICH E Safety - ANSWER -ICH S Multidisciplinary - ANSWER -ICH M guidance for industry, consolidated guideance - ANSWER -ICH E 6 Clinical Safety Data Management Definitions and Standards - ANSWER -ICH E2A Safety pharmacology studies for human pharmaceuticals - ANSWER -ICH S7A Electronic records, electronic signatures - ANSWER -21 CFR Part 11 Informed Consent - ANSWER -21 CFR Part 50 Financial Disclosures - ANSWER -21 CFR Part 54...

SOCRA Exam Questions With 100% Correct Answers When isn't an IND application needed? - answerIND Application is not needed if investigation does not support change in labeling. What information must the general IND include? (21 CFR Part 312.23) - answer-FDA Form 1571 -FDA Form 1571 cover sheet -Table of contents -Investigative Plan -Investigator's brochure -Protocol -Chemistry/Manufacturing information -Pharmacology/Toxicology -Previous human research/literature information -Addi...

When isn't an IND application needed? - IND Application is not needed if investigation does not support change in labeling. What information must the general IND include? (21 CFR Part 312.23) - -FDA Form 1571 -FDA Form 1571 cover sheet -Table of contents -Investigative Plan -Investigator's brochure -Protocol -Chemistry/Manufacturing information -Pharmacology/Toxicology -Previous human research/literature information -Additional information (drug dependence and abuse potential) ...

April 30 1996 ICH GCP Development Date Quality ICH Q Efficacy ICH E Safety ICH S Multidisciplinary ICH M guidance for industry, consolidated guideance ICH E 6 Clinical Safety Data Management Definitions and Standards ICH E2A Safety pharmacology studies for human pharmaceuticals ICH S7A Electronic records, electronic signatures 21 CFR Part 11 Informed Consent 21 CFR Part 50 Financial Disclosures 21 CFR Part 54 Institutional Review Board 21 CFR Part 56 IND Appli...

April 30 1996 - ANSWERSICH GCP Development Date Quality - ANSWERSICH Q Efficacy - ANSWERSICH E Safety - ANSWERSICH S Multidisciplinary - ANSWERSICH M guidance for industry, consolidated guideance - ANSWERSICH E 6 Clinical Safety Data Management Definitions and Standards - ANSWERSICH E2A Safety pharmacology studies for human pharmaceuticals - ANSWERSICH S7A Electronic records, electronic signatures - ANSWERS21 CFR Part 11 Informed Consent - ANSWERS21 CFR Part 50 Fina...

Biometrics - ANSWER A method of verifying an individual's identity based on measurement of the individual's physical features or repeatable actions where those features and or actions are both unique to that individual and measurable. (21 CFR, Sec. 11.3) Closed System - ANSWER An environment in which system access is controlled by persons who are responsible for the content of electronic records that are on the system. (21 CFR, Sec. 11.3) Digital Signature - ANSWER An electronic signatur...

April 30 1996 - ANSWER-ICH GCP Development Date Quality - ANSWER-ICH Q Efficacy - ANSWER-ICH E Safety - ANSWER-ICH S Multidisciplinary - ANSWER-ICH M guidance for industry, consolidated guideance - ANSWER-ICH E 6 Clinical Safety Data Management Definitions and Standards - ANSWER-ICH E2A Safety pharmacology studies for human pharmaceuticals - ANSWER-ICH S7A Electronic records, electronic signatures - ANSWER-21 CFR Part 11 Informed Consent - ANSWER-21 CFR Part 50 Fina...

CCRP SOCRA Exam Graded A+ April 30 1996 - ANSICH GCP Development Date Quality - ANSICH Q Efficacy - ANSICH E Safety - ANSICH S Multidisciplinary - ANSICH M guidance for industry, consolidated guideance - ANSICH E 6 Clinical Safety Data Management Definitions and Standards - ANSICH E2A Safety pharmacology studies for human pharmaceuticals - ANSICH S7A Electronic records, electronic signatures - ANS21 CFR Part 11 Informed Consent - ANS21 CFR Part 50 Financial Disclosures - ANS21 CFR Par...